Please assess the completion status of the following clinical trial:

Trial Title: Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Nosocomial or severe community-acquired pneumonia due to Methicillin-Resistant Staphylococcus aureus~* Must be mechanically ventilated in intensive care unit~Exclusion Criteria:~* Non-bacterial pneumonia, such as viral, fungal, tuberculosis infections~* Underlying respiratory condition: bronchiectasis, post-tuberculosis, chronic obstructive pulmonary disease or asthma~* Complicated pneumonia, such as empyema, parapneumonic effusion requiring chest tube or drainage~* Already or previous treated with intravenous vancomycin (Not pneumonia)~* Adverse reaction due to inhaled ventolin before treatment of aerosolized vancomycin~* Hypersensitivity of vancomycin or glycopeptide antibiotics~* Positive culture of Enterococcus in respiratory specimen~* Pregnant or Breast-feeding patient~* Immunocompromised hosts: more than 1mg/kg of corticosteroid users for more than 3 months, transplantation recipients, AIDS patients~* Another aerosolized antibiotics within 48 hours of study enrollment~* Not adherent to mechanical ventilation protocol of this study~* Not arterial line monitoring~* Vancomycin minimum inhibitory concentration \>= 2㎍/㎖ of cultured Staphylococcus aureus

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Aerosolized Vancomycin (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).